TechTarget (TTGT) director awarded 5,000 stock options at $3.66 exercise price
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
TechTarget director Christina Van Houten received a stock option grant for 5,000 shares of common stock. The award, granted under TechTarget’s 2026 Non-Employee Director Compensation Plan and 2024 Incentive Plan, has an exercise price of $3.66 per share and is exercisable from June 11, 2027 until June 10, 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Van Houten Christina
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 5,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 5,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 5,000 shares
Exercise price: $3.66 per share
Exercisability date: June 11, 2027
+1 more
4 metrics
Option grant size
5,000 shares
Stock option award to director Christina Van Houten
Exercise price
$3.66 per share
Stock option right to buy TechTarget common stock
Exercisability date
June 11, 2027
Earliest exercise date for the 5,000-share option
Expiration date
June 10, 2036
Last date to exercise the stock option grant
Key Terms
Stock Option (Right to Buy), 2026 Non-Employee Director Compensation Plan, 2024 Incentive Plan, Form 4
4 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
2026 Non-Employee Director Compensation Plan financial
"granted in accordance with the TechTarget, Inc. 2026 Non-Employee Director Compensation Plan"
2024 Incentive Plan financial
"and the 2024 Incentive Plan and represents a right to purchase 5,000 shares"
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
What insider transaction did TechTarget (TTGT) report for Christina Van Houten?
TechTarget reported that director Christina Van Houten received a stock option grant for 5,000 shares of common stock. The award is a compensation-related grant, not an open-market purchase or sale, and represents a right to buy shares at a fixed exercise price.
What is the exercise price of Christina Van Houten’s TechTarget (TTGT) stock options?
The stock option grant to Christina Van Houten has an exercise price of $3.66 per share. This means she can buy up to 5,000 TechTarget common shares at $3.66 each once the option becomes exercisable under the plan terms.
When can Christina Van Houten exercise her TechTarget (TTGT) stock options?
Christina Van Houten’s stock options become exercisable on June 11, 2027. From that date until their expiration, she may choose to purchase up to 5,000 TechTarget common shares at the fixed exercise price specified in the award.
When do Christina Van Houten’s TechTarget (TTGT) stock options expire?
The reported stock options for Christina Van Houten expire on June 10, 2036. After that expiration date, any unexercised portion of the 5,000-share grant will lapse and can no longer be used to purchase TechTarget common stock.
Is Christina Van Houten’s TechTarget (TTGT) Form 4 transaction a market sale or purchase?
The Form 4 shows a grant of stock options, not a market sale or purchase. It is classified as a grant or award acquisition, providing a right to buy 5,000 TechTarget shares at $3.66 per share in the future.
Under which plans were Christina Van Houten’s TechTarget (TTGT) options granted?
The stock options were granted under TechTarget’s 2026 Non-Employee Director Compensation Plan and its 2024 Incentive Plan. These company plans govern equity-based awards, including the 5,000-share stock option issued to director Christina Van Houten.